Patient basic information Patient: Mr. Eric (Eric Wilson) Nationality: Cuba Diagnosis: Myocardial infarction Diagnostic Hospital: University of Hong Kong Shenzhen Hospital Treatment: Blood stem cell transplant + chemotherapy Holidays: 176 days Treatment cost: about 339382 yuan Treatment effect: Rehabilitation Outpatient Description: Mr. Eric is from Cuba and was diagnosed with Myocardial infarction locally.
After arriving at the Shenzhen Hospital of the University of Hong Kong, for the first time, the International Medical Services team arranged multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided full translation, accompaniment and landing services. During the treatment process, the team of experts at the Shenzhen Hospital of the University of Hong Kong used a comprehensive set of blood stem cell transplants + chemotherapy, during which the medical team closely monitored the patient's indicators, dynamic adjustment programs. After 176 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached hospital standards.
Treatment results The patient finally recovered from the hospital. At the time of his discharge, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. The patient commented: 'We are impressed by the level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals, and every link from the ground to the hospital is arranged well.
'Mr. Liu Eric criticized the case as a typical case of cross-border suspected serious medical conditions. The University of Hong Kong Shenzhen Hospital, based on a multidisciplinary collaborative mechanism, has developed a blood stem cell transplant + chemotherapy program to treat myocardial infarction, which reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a shorthand for the regulation of international visitor medical services.